Skip to main content

Table 3 Application of 2016 Chinese CAP guidelines in hospitalized patients over 65 years with risk factors of Pseudomonas aeruginosa infection (n = 815)

From: Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia

Regimen General ward inpatients (n = 722) ICU patients (n = 93)
Consistent with guideline 348(48.2) 22(23.7)
 Antipseudomonal β-lactam 247(34.2) 0(0)
 Antipseudomonal fluoroquinolone 85(11.8) 0(0)
 Antipseudomonal β-lactam + macrolide 16(2.2) 0(0)
 Antipseudomonal β-lactam +fluoroquinolone 0(0) 21(22.6)
 Antipseudomonal β-lactam+ aminoglycosides 0(0) 1(1.1)
Undertreated by guideline 165(22.9) 69(74.2)
 β-lactam 132(18.3) 10(10.8)
 Antipseudomonal β-lactam 0(0) 32(34.4)
 Macrolide 5(0.7) 0(0)
 β-lactam + macrolide 23(3.2) 1(1.1)
 Antipseudomonal fluoroquinolone +/− β-lactam/ other 0(0) 9(9.7)
 Antipseudomonal β-lactam + macrolide 0(0) 4(4.3)
 Antipseudomonal fluoroquinolone + macrolide 0(0) 2(2.2)
 Other combination 5(0.7) 11(11.8)
Overtreated by guideline 209(28.9) 2(2.2)
 Antipseudomonal β-lactam + antipseudomonal fluoroquinolone + macrolide /other 6(0.8) 2(2.2)
 Antipseudomonal β-lactam + antipseudomonal fluoroquinolone 96(13.3) 0(0)
 Antipseudomonal fluoroquinolone +β-lactam 65(9.0) 0(0)
 Antipseudomonal fluoroquinolone+ macrolide 5(0.7) 0(0)
 Antipseudomonal fluoroquinolone + other 13(1.8) 0(0)
 Antipseudomonal β-lactam + other 24(3.3) 0(0)
  1. Data on empirical antimicrobial regimens in 12 patients were missing
  2. other = imidazoles, lincomycin, fosfomycin, glycopeptides and antifungal agents